108 related articles for article (PubMed ID: 12512232)
1. The SH-metabolite I of erdosteine, a mucolytic drug, enhances the inhibitory effect of salbutamol on the respiratory burst of neutrophils.
Dal Sasso M; Bovio C; Culici M; Fonti E; Braga PC
Drugs Exp Clin Res; 2002; 28(4):147-54. PubMed ID: 12512232
[TBL] [Abstract][Full Text] [Related]
2. A combination of budesonide and the SH-metabolite I of erdosteine acts synergistically in reducing chemiluminescence during human neutrophil respiratory burst.
Dal Sasso M; Culici M; Guffanti EE; Bianchi T; Fonti E; Braga PC
Pharmacology; 2005 Jun; 74(3):127-34. PubMed ID: 15753624
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of metabolite I of erdosteine on the generation of nitric oxide and peroxynitrite chemiluminescence by human neutrophils.
Dal Sasso M; Culici M; Bianchi T; Fonti E; Braga PC
Pharmacology; 2004 Jul; 71(3):120-7. PubMed ID: 15161993
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the antioxidant activity of the SH metabolite I of erdosteine on human neutrophil oxidative bursts.
Braga PC; Dal Sasso M; Zuccotti T
Arzneimittelforschung; 2000 Aug; 50(8):739-46. PubMed ID: 10994158
[TBL] [Abstract][Full Text] [Related]
5. Erdosteine enhances airway response to salbutamol in patients with mild-to-moderate COPD.
Dal Negro R; Visconti M; Trevisan F; Bertacco S; Micheletto C; Tognella S
Ther Adv Respir Dis; 2008 Oct; 2(5):271-7. PubMed ID: 19124377
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant effect of sulphurous thermal water on human neutrophil bursts: chemiluminescence evaluation.
Braga PC; Sambataro G; Dal Sasso M; Culici M; Alfieri M; Nappi G
Respiration; 2008; 75(2):193-201. PubMed ID: 17804898
[TBL] [Abstract][Full Text] [Related]
7. Effect of metabolite I of erdosteine on the release of human neutrophil elastase.
Braga PC; Dal Sasso M; Culici M; Verducci P; Lo Verso R; Marabini L
Pharmacology; 2006; 77(3):150-4. PubMed ID: 16825803
[TBL] [Abstract][Full Text] [Related]
8. Effects of nedocromil sodium on the oxidative burst of polymorphonuclear leukocytes: comparison with salbutamol.
Braga PC; Mancini L; Guffanti EE; Dal Sasso M; Sala M; Reggio S
Drugs Exp Clin Res; 1997; 23(1):33-8. PubMed ID: 9093820
[TBL] [Abstract][Full Text] [Related]
9. The combination of the SH metabolite of erdosteine (a mucoactive drug) and ciprofloxacin increases the inhibition of bacterial adhesiveness achieved by ciprofloxacin alone.
Dal SM; Bovio C; Culici M; Braga PC
Drugs Exp Clin Res; 2002; 28(2-3):75-82. PubMed ID: 12224380
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial.
Dal Negro RW; Visconti M; Turco P
Pulm Pharmacol Ther; 2015 Aug; 33():47-51. PubMed ID: 26116425
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of zafirlukast on respiratory bursts of human neutrophils.
Braga PC; Dal Sasso M; Dal Negro R
Drugs Exp Clin Res; 2002; 28(4):133-45. PubMed ID: 12512231
[TBL] [Abstract][Full Text] [Related]
12. The effect of erdosteine and its active metabolite on reactive oxygen species production by inflammatory cells.
Miyake K; Kaise T; Hosoe H; Akuta K; Manabe H; Ohmori K
Inflamm Res; 1999 Apr; 48(4):205-9. PubMed ID: 10344471
[TBL] [Abstract][Full Text] [Related]
13. Effect of the mucoactive drug nacystelyn on the respiratory burst of human blood polymorphonuclear neutrophils.
Nagy AM; Vanderbist F; Parij N; Maes P; Fondu P; Nève J
Pulm Pharmacol Ther; 1997; 10(5-6):287-92. PubMed ID: 9778492
[TBL] [Abstract][Full Text] [Related]
14. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
[TBL] [Abstract][Full Text] [Related]
15. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant activity of bisabolol: inhibitory effects on chemiluminescence of human neutrophil bursts and cell-free systems.
Braga PC; Dal Sasso M; Fonti E; Culici M
Pharmacology; 2009; 83(2):110-5. PubMed ID: 19096233
[TBL] [Abstract][Full Text] [Related]
17. Effects of erdosteine and its metabolites on bacterial adhesiveness.
Braga PC; Dal Sasso M; Sala MT; Gianelle V
Arzneimittelforschung; 1999 Apr; 49(4):344-50. PubMed ID: 10337454
[TBL] [Abstract][Full Text] [Related]
18. Erdosteine: antitussive and anti-inflammatory effects.
Dal Negro RW
Lung; 2008; 186 Suppl 1():S70-3. PubMed ID: 18185958
[TBL] [Abstract][Full Text] [Related]
19. Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent.
Cazzola M; Page C; Rogliani P; Calzetta L; Matera MG
Drugs; 2020 Nov; 80(17):1799-1809. PubMed ID: 33025535
[TBL] [Abstract][Full Text] [Related]
20. Erdosteine for COPD exacerbations.
Drug Ther Bull; 2008 Oct; 46(10):79-80. PubMed ID: 18832259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
